Howley was born in New Brunswick, New Jersey. He graduated in 1968 from Princeton University with an A.B. in chemistry and in 1970 from Rutgers University with an M.M.S. (Master of Medical Science) degree. In 1972 he graduated with an M.D. from Harvard Medical School. From 1972 to 1973 he worked as an intern in pathology at Massachusetts General Hospital. He was a research associate from 1973 to 1975 at the National Institute of Allergy and Infectious Diseases (NIAID) in Bethesda, Maryland. In 1977 he was granted board certification in anatomic pathology.
At the NCI's Laboratory of Pathology, Howley was from 1975 to 1976 a resident, from 1976 to 1977 a junior staff pathologist, from 1977 to 1979 a senior investigator, and from 1979 to 1984 Chief of the Viral Oncology and Molecular Pathology Section. From 1984 to 1993 he was Chief of the NCI's Laboratory of Tumor Virus Biology.
In 1991, Howley became the George Fabyan Professor of Comparative Pathology at Harvard Medical School.[4]
He was the president of the American Society for Virology from 1998 to 1999[5] and the president of the American Society for Investigative Pathology in 2006.[6]
By 2009 he was the Shattuck Professor of Pathology.[7]
Howley is considered to be a leader in research on papillomaviruses. Howley and his co-workers created gene maps of many species of papillomaviruses and analyzed their transcription patterns and systems of transcription regulation. The research identified papillomavirus oncogenes and the molecular mechanisms of their damaging effects. This work is considered fundamental for the understanding of the pathogenesis of papillomaviruses at the molecular level.[8]
Peter M. Howley should not be confused with Paul M. Howley, who is a managing director of the vaccine biotechnology firm VAXMED Pty Ltd in Melbourne, Australia.[12]
2015 — NCI Outstanding Investigator Award, National Cancer Institute[22]
Selected publications
Lowy, Douglas R.; Dvoretzky, Israel; Shober, Ralph; Law, Ming-Fan; Engel, Linda; Howley, Peter M. (1980). "In vitro tumorigenic transformation by a defined sub-genomic fragment of bovine papilloma virus DNA". Nature. 287 (5777): 72–74. Bibcode:1980Natur.287...72L. doi:10.1038/287072a0. PMID6251381. S2CID4278780. 1980
Dyson, N.; Howley, P.; Munger, K.; Harlow, E. (1989). "The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product". Science. 243 (4893): 934–937. Bibcode:1989Sci...243..934D. doi:10.1126/science.2537532. PMID2537532. 1989
Huang, L.; Kinnucan, E.; Wang, G.; Beaudenon, S.; Howley, P. M.; Huibregtse, J. M.; Pavletich, N. P. (1999). "Structure of an E6AP-UbcH7 Complex: Insights into Ubiquitination by the E2-E3 Enzyme Cascade". Science. 286 (5443): 1321–1326. doi:10.1126/science.286.5443.1321. PMID10558980. 1999
^"Annual Review of Pathology: Mechanisms of Disease. Volume 2: 2007. Edited by Abul K Abbas, , Stephen J Galli, and , Peter M Howley. Palo Alto (California): Annual Reviews. $55.00. Xii + 429 p; ill.; no index. ISBN: 978-0-8243-4302-6. 2007". The Quarterly Review of Biology. 82 (3): 311. 2007. doi:10.1086/523214.